Testimonials

WHAT CLIENTS SAY ABOUT LIBERI GROUP

Image
"“When we realized our limited internal bandwidth as an emerging biotech was not adequate to pursue critical fundraising needs, we hired The Liberi Group. The Liberi Group associates have engaged with a sincere interest in the success of our drug development projects and are a pleasure to work with as true collaborative partners. They bring a large, valuable and well established network of national and international investor relationships plus excellent current knowledge of market values and deal structures to our mission. The Liberi Group has proven to be an essential partner, filling gaps in our internal expertise and helping us to secure the next round of investment for advancing our pipeline of cancer therapeutics.”"
Tim Hazlehurst, CEO

Modulation Therapeutics

USA
Glaceum
"“Liberi Group has been instrumental in helping me expand the outreach list and better understand the industry by providing feedback. Liberi Group amazed me by contacting over 200 companies and getting me the valuable feedback from around 60 companies within the first 3 months, which saved me a huge amount of time and effort while helping me to see an accurate picture of my business.”"
Keun-Wan Lim, Executive Director, BD

Glaceum

South-Korea
Neox Biotech
"“Liberi Group firstly serves as our bridge to pipeline assets, technology platforms, and capital markets internationally, critically evaluating the company's strategic fit. The team formed to support neoX has consistently been very capable and helpful in organizing the business development process. Secondly, Liberi Group has been our consultant in developing strategies and exploring business directions in the face of challenging situations. This level of partnership is beyond what a start-up biotech could typically imagine. Frans and the team spend quality meeting time with us to align the vision and pathway for neoX to realize our value through creative deal-making.”"
Fan Liu, CEO

NeoX

China
Imugene
"“Working with the Liberi Group has been a pleasure. They are professional, collaborative, and understand the partner’s objectives and work diligently to help achieve the goals.”"
Monil Shah - CBO

Imugene

Australia
Mthera pharma
"The Liberi Group has been working with MTHERA for some time now, and we appreciate all the members working diligently for MTHERA’s business development in the global pharmaceutical industry as one team. The CEO of the Liberi Group, Frans Trouwen is one of the most active and passionate leaders I’ve met and Bram de Jong, Corporate Client Manager of the Liberi Group, has been helpful with preparing for our incoming meeting requests with global pharmaceutical companies. We look forward to much more successful outcome with the Liberi Group as we progress on the journey for completion of our US clinical trials and globalization of MTHERA."
Hyun Joo Park, Manager, Management Strategy - Law Department

MThera

South Korea
AGV Discovery
"If I had to describe Liberi Group in a few words, it would be professionalism, efficiency and trust. In fact, we have been working with the team for almost 10 years now and thanks to a real partnership relationship that has been established throughout these years, our company is now on the path to scientific and commercial success. Thanks for all to Liberi Group."
Cédric Bories, President

AGV

France
logo amcure
"Frans and Liberi Group were instrumental in establishing our collaboration and licensing agreement with Hinova Pharmaceuticals China. Through their network, Liberi Group had identified Hinova as a potential partner and supported Amcure in all aspects and negotiations to complete this transaction. Thank you, Liberi Group."
Klaus Dembowsky, MD, PhD, CEO

Amcure

Germany
Image
"Liberi has proven to be highly valuable for Sharp Therapeutics. Their consistent diligence ensures an ongoing flow of potential partners. The breadth of their contacts is impressive, connecting us with pivotal players in the industry. Most notably, the well-managed process allows our team to remain focused on our core responsibilities while Liberi Group is landscaping the industry and engaging with potential partners. Beyond their partnering expertise, the team at Liberi Group is a genuine pleasure to work with — always professional and yet personable. I would definitely recommend their services to other leaders in the biotech space."
Scott Sneddon, Founder and CEO

Sharp Therapeutics

USA
Peaccel
"Liberi Group spares no effort and makes it a point of honor to bring every customer to a deal. Perseverance and professionalism are highly appreciated traits."
Frédéric Cadet, President of the Board

Peaccel

France
MenoGenix
"Working with Liberi Group has been extremely valuable and has helped us expand our global network of prospective industry partners and investors in the women’s health pharmaceutical industry. They manage the business development and are an integral part of the our organization. Working with them is a true partnership that strengthens the company. We appreciate all that they’ve done and are doing on our behalf."
Richard Duke, PhD, CEO

MenoGenix

USA
Get in touch